Prior authorization, insurance denials, appeals, formularies, OTC guidance, chronic condition medications, managed care careers, and what's changing in pharmacy — written in plain English by a pharmacist who reviews this for a living.
Why health plans require it, how the process works, and what to do while you wait.
Eight reasons a prescription doesn't process the first time — and which ones you can fix without an appeal.
An eight-step process for building an appeal that actually addresses the plan's stated reason for denial.
Why plans require a preferred medication first, what counts as "tried and failed," and how to request an exception.
How covered-drug lists, tiers, and preferred medications work — and what to do when yours isn't on it.
Eleven common reasons Wegovy gets denied, from benefit exclusions to missing documentation — plus a free checklist.
When combining is appropriate, how to track two separate dose ledgers, and who should ask a pharmacist first.
How to choose between the two most common OTC pain relievers based on symptoms, medical history, and pregnancy.
Antihistamines, nasal sprays, eye drops, and decongestants — matched to the symptom you actually have.
How antacids, H2 blockers, and proton pump inhibitors differ — and when heartburn needs medical evaluation.
Anticoagulants vs. antiplatelets, bleeding risk, INR monitoring, and OTC/supplement interactions to watch for.
Which decongestants and pain relievers to watch for, and symptom-specific alternatives to ask your pharmacist about.
Why controller and rescue inhalers serve different roles — and why technique matters as much as the prescription.
What dextromethorphan, guaifenesin, antihistamines, and decongestants actually do — and how to avoid duplicate ingredients.
Why sedating antihistamines, sleep aids, NSAIDs, and combination products deserve extra caution with age.
Two ingredients, four brands, four different FDA-approval pathways — plus an interactive comparison tool.
How statins lower cardiovascular risk, and what to know about muscle pain, liver tests, and pregnancy.
Metformin, GLP-1 medicines, SGLT2 inhibitors, sulfonylureas, and insulin — compared by how they work and who they fit.
How ACE inhibitors, ARBs, diuretics, calcium channel blockers, and beta-blockers each work — and why the class matters.
Education, rotations, residency options, transferable skills, and how to rewrite your résumé for managed care.
Nine career tracks, entry routes by background, resume translation, and a free interactive role matcher.
A framework and worked examples for approvals, denials, pends, step therapy, appeals, and escalation — plus a phrase bank and draft-builder tool.
Common questions, clinical scenarios, the STAR method, and how to translate retail experience for managed care.
The real job titles to search, where to look, licensure and travel realities, and scam red flags to watch for.
Responsibilities, patient contact, workflow, and which environment might fit your strengths.
Prior authorization, step therapy, quantity limits, formularies, and drug utilization review, explained together.
What the role reviews, where these pharmacists work, and the skills that separate a strong reviewer from a checklist-clicker.
Why multi-state CE tracking gets complicated fast, and a free interactive planner to keep it organized.
One eye vs. both eyes, drop-factor sensitivity, PRN and taper worked examples, and single-use containers — plus a free calculator.
Formulas, common package counts for 15+ products, PRN maximum-use methods, and worked examples — plus a free calculator.
Tablets, liquids, topicals, insulin, injectables, weekly dosing, and six-phase tapers — plus a free calculator.
How AI is already being used in medication safety, prescription processing, and personalized therapy — and why it's reshaping the pharmacist's role rather than replacing it.
The FDA's Pharmacy Compounding Advisory Committee votes on BPC-157 this week. Here's what's actually being decided — and what it isn't.
BPC-157 is promoted for injury recovery, gut health and inflammation. A pharmacist examines the claimed benefits, the actual human evidence, the risks, and its FDA status.